GR1000419B - Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. - Google Patents

Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.

Info

Publication number
GR1000419B
GR1000419B GR900100015A GR900100015A GR1000419B GR 1000419 B GR1000419 B GR 1000419B GR 900100015 A GR900100015 A GR 900100015A GR 900100015 A GR900100015 A GR 900100015A GR 1000419 B GR1000419 B GR 1000419B
Authority
GR
Greece
Prior art keywords
astestive
resistance operation
traffic form
traffic
resistance
Prior art date
Application number
GR900100015A
Other languages
English (en)
Other versions
GR900100015A (en
Inventor
Rosa Stephen C De
Joseph C Deters
David R Swanson
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of GR900100015A publication Critical patent/GR900100015A/el
Publication of GR1000419B publication Critical patent/GR1000419B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Αποκαλύπτεται μια μορφή δοσολογίας (10) περιλαμβάνουσα ένα μέλος που επιλέγεται από την ομάδα που αποτελείται από nicardipine και τα φαρμακευτικώς αποδεκτά άλατά της για χορήγηση σε έναν ασθενή που χριεάζεται καρδιοαγγειακή θεραπεία. ω
GR900100015A 1989-01-30 1990-01-10 Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. GR1000419B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30370689A 1989-01-30 1989-01-30

Publications (2)

Publication Number Publication Date
GR900100015A GR900100015A (en) 1991-06-07
GR1000419B true GR1000419B (el) 1992-06-30

Family

ID=23173326

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100015A GR1000419B (el) 1989-01-30 1990-01-10 Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.

Country Status (11)

Country Link
EP (1) EP0455648B1 (el)
JP (1) JPH04503058A (el)
AU (1) AU621182B2 (el)
CA (1) CA2007106A1 (el)
DK (1) DK23790A (el)
ES (2) ES2054333T3 (el)
FI (1) FI913608A0 (el)
GR (1) GR1000419B (el)
IE (1) IE61872B1 (el)
PT (1) PT92994B (el)
WO (1) WO1990008536A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
DK1035834T3 (da) * 1997-12-05 2002-07-08 Alza Corp Osmotisk doseringsform omfattende en første og anden coating
WO1999051208A1 (en) 1998-04-03 1999-10-14 Bm Research A/S Controlled release composition
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
AU2003275953A1 (en) 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
EP1610768B1 (en) 2003-03-26 2008-07-02 Egalet A/S Matrix compositions for controlled delivery of drug substances
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
JP2008528629A (ja) * 2005-01-27 2008-07-31 アルザ・コーポレーシヨン 高流動性膜を有する経口浸透薬用量形態
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
AU2013285988A1 (en) 2012-07-06 2015-02-12 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form

Also Published As

Publication number Publication date
DK23790A (da) 1990-07-31
IE900296L (en) 1990-07-30
FI913608A7 (fi) 1991-07-29
GR900100015A (en) 1991-06-07
DK23790D0 (da) 1990-01-29
AU621182B2 (en) 1992-03-05
ES2026304A6 (es) 1992-04-16
EP0455648A1 (en) 1991-11-13
AU4811490A (en) 1990-08-24
PT92994B (pt) 1995-12-29
EP0455648B1 (en) 1993-03-10
IE61872B1 (en) 1994-11-30
CA2007106A1 (en) 1990-07-30
ES2054333T3 (es) 1994-08-01
PT92994A (pt) 1990-07-31
FI913608A0 (fi) 1991-07-29
JPH04503058A (ja) 1992-06-04
WO1990008536A1 (en) 1990-08-09

Similar Documents

Publication Publication Date Title
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
IL86053A0 (en) Rapidly dissoluble medicinal dosage unit and its manufacture
FR2622798B1 (fr) Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
GR1000465B (el) Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος.
DK0459666T3 (da) Lægemidler mod impotens
NO922936D0 (no) Fremstilling av fettsyremedikamenter
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
IT1235153B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
DE68905613D1 (de) Pharmazeutische zubereitung.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
IT1229491B (it) Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
ATE59550T1 (de) Chlorpheniramine therapie.
IT1216556B (it) Derivati peptidici del3_aminodiidrotiofen_2_one, loro preparazione e impiego terapeutico.
NO912497L (no) Doseringsform for administrering av kalsiumantagonist.
DK429589D0 (da) Transdermalt laegemiddelpraeparat
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung